These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6328053)

  • 1. Noncontraceptive estrogen use and the risk of breast cancer.
    Kaufman DW; Miller DR; Rosenberg L; Helmrich SP; Stolley P; Schottenfeld D; Shapiro S
    JAMA; 1984 Jul; 252(1):63-7. PubMed ID: 6328053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
    Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of breast cancer after estrogen and estrogen-progestin replacement.
    Bergkvist L; Adami HO; Persson I; Hoover R; Schairer C
    N Engl J Med; 1989 Aug; 321(5):293-7. PubMed ID: 2546079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncontraceptive estrogens and myocardial infarction in young women.
    Rosenberg L; Slone D; Shapiro S; Kaufman D; Stolley PD; Miettinen OS
    JAMA; 1980 Jul; 244(4):339-42. PubMed ID: 6248650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk after estrogen replacement therapy: results from the Toronto Breast Cancer Study.
    Palmer JR; Rosenberg L; Clarke EA; Miller DR; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1386-95; discussion 1396-401. PubMed ID: 1663701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncontraceptive estrogens and nonfatal myocardial infarction.
    Jick H; Dinan B; Rothman KJ
    JAMA; 1978 Apr; 239(14):1407-9. PubMed ID: 204804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopausal estrogen use and risk of breast cancer.
    Brinton LA; Hoover RN; Szklo M; Fraumeni JF
    Cancer; 1981 May; 47(10):2517-22. PubMed ID: 6268273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugated estrogens and breast cancer risk in women.
    Hoover R; Glass A; Finkle WD; Azevedo D; Milne K
    J Natl Cancer Inst; 1981 Oct; 67(4):815-20. PubMed ID: 6268883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncontraceptive estrogen use and epithelial ovarian cancer.
    Kaufman DW; Kelly JP; Welch WR; Rosenberg L; Stolley PD; Warshauer ME; Lewis J; Woodruff J; Shapiro S
    Am J Epidemiol; 1989 Dec; 130(6):1142-51. PubMed ID: 2589307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal estrogens and breast cancer.
    Hoover R; Gray LA; Cole P; MacMahon B
    N Engl J Med; 1976 Aug; 295(8):401-5. PubMed ID: 180409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center.
    N Engl J Med; 1974 Jan; 290(1):15-9. PubMed ID: 4357161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium.
    Shapiro S; Kaufman DW; Slone D; Rosenberg L; Miettinen OS; Stolley PD; Rosenshein NB; Watring WG; Leavitt T; Knapp RC
    N Engl J Med; 1980 Aug; 303(9):485-9. PubMed ID: 6248785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen replacement therapy and benign breast disease.
    Trapido EJ; Brinton LA; Schairer C; Hoover R
    J Natl Cancer Inst; 1984 Nov; 73(5):1101-5. PubMed ID: 6092767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estrogen therapy in carcinoma of the breast (author's transl)].
    Völker W; Kannengiesser U; Majewski A
    Geburtshilfe Frauenheilkd; 1980 Feb; 40(2):125-32. PubMed ID: 6245009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-contraceptive exogenous estrogens and risk of breast cancer: a review.
    Thomas DB
    Breast Cancer Res Treat; 1982; 2(3):203-11. PubMed ID: 6295528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
    Vassilopoulou-Sellin R; Theriault RL
    J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens.
    Shapiro S; Kelly JP; Rosenberg L; Kaufman DW; Helmrich SP; Rosenshein NB; Lewis JL; Knapp RC; Stolley PD; Schottenfeld D
    N Engl J Med; 1985 Oct; 313(16):969-72. PubMed ID: 2995807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study.
    Troisi RJ; Speizer FE; Willett WC; Trichopoulos D; Rosner B
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1183-8. PubMed ID: 7551368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.